Mason Carrico
Stock Analyst at Stephens & Co.
(1.81)
# 3,195
Out of 4,910 analysts
71
Total ratings
35.48%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Mason Carrico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCEL Vericel | Reiterates: Overweight | $67 | $37.98 | +76.41% | 3 | Jun 16, 2025 | |
| ILMN Illumina | Reiterates: Overweight | $105 | $102.03 | +2.91% | 8 | May 20, 2025 | |
| PACB Pacific Biosciences of California | Reiterates: Overweight | $1.8 | $1.62 | +11.11% | 5 | May 15, 2025 | |
| TXG 10x Genomics | Reiterates: Overweight | $14 | $12.99 | +7.78% | 6 | May 15, 2025 | |
| HOLX Hologic | Maintains: Overweight | $77 → $70 | $65.37 | +7.08% | 4 | May 13, 2025 | |
| CDNA CareDx | Reiterates: Overweight | $40 | $13.02 | +207.22% | 10 | May 5, 2025 | |
| GKOS Glaukos | Maintains: Overweight | $140 → $115 | $96.36 | +19.34% | 1 | May 2, 2025 | |
| VCYT Veracyte | Reiterates: Overweight | $45 | $23.51 | +91.41% | 7 | Mar 26, 2025 | |
| GH Guardant Health | Reiterates: Overweight | $55 | $46.25 | +18.92% | 5 | Mar 26, 2025 | |
| CTKB Cytek Biosciences | Reiterates: Overweight | $6 | $3.25 | +84.90% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $17 | $18.28 | -6.98% | 2 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $52 | $43.47 | +19.62% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $20 | $4.59 | +335.73% | 4 | Jan 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $41 | $16.32 | +151.23% | 7 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $125 | $139.92 | -10.66% | 4 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $19 | $6.42 | +195.95% | 1 | Jul 30, 2024 |
Vericel
Jun 16, 2025
Reiterates: Overweight
Price Target: $67
Current: $37.98
Upside: +76.41%
Illumina
May 20, 2025
Reiterates: Overweight
Price Target: $105
Current: $102.03
Upside: +2.91%
Pacific Biosciences of California
May 15, 2025
Reiterates: Overweight
Price Target: $1.8
Current: $1.62
Upside: +11.11%
10x Genomics
May 15, 2025
Reiterates: Overweight
Price Target: $14
Current: $12.99
Upside: +7.78%
Hologic
May 13, 2025
Maintains: Overweight
Price Target: $77 → $70
Current: $65.37
Upside: +7.08%
CareDx
May 5, 2025
Reiterates: Overweight
Price Target: $40
Current: $13.02
Upside: +207.22%
Glaukos
May 2, 2025
Maintains: Overweight
Price Target: $140 → $115
Current: $96.36
Upside: +19.34%
Veracyte
Mar 26, 2025
Reiterates: Overweight
Price Target: $45
Current: $23.51
Upside: +91.41%
Guardant Health
Mar 26, 2025
Reiterates: Overweight
Price Target: $55
Current: $46.25
Upside: +18.92%
Cytek Biosciences
Mar 19, 2025
Reiterates: Overweight
Price Target: $6
Current: $3.25
Upside: +84.90%
Mar 18, 2025
Reiterates: Equal-Weight
Price Target: $17
Current: $18.28
Upside: -6.98%
Mar 6, 2025
Reiterates: Overweight
Price Target: $52
Current: $43.47
Upside: +19.62%
Jan 16, 2025
Reiterates: Equal-Weight
Price Target: $20
Current: $4.59
Upside: +335.73%
Jan 2, 2025
Reiterates: Overweight
Price Target: $41
Current: $16.32
Upside: +151.23%
Aug 9, 2024
Reiterates: Overweight
Price Target: $125
Current: $139.92
Upside: -10.66%
Jul 30, 2024
Reiterates: Overweight
Price Target: $19
Current: $6.42
Upside: +195.95%